相关人员
Andrew Payne
Andrew is a senior associate in the intellectual property team and provides advice on contentious and non-contentious patent issues. He has a particular interest in advising life sciences companies, following a previous career as a medicinal chemist in the pharmaceutical industry.
显示完整简历
隐藏完整简历
更多
显示更少
更多
显示更少
职业发展
| Since 2020 | Senior Associate, Taylor Wessing |
| 2015 - 2020 | Associate, Taylor Wessing |
| 2013 - 2015 | Trainee Solicitor , CMS Cameron McKenna |
| 2009 - 2013 | Group Leader, Medicinal Chemistry at Eisai |
| 2000 - 2009 | Team Leader, GlaxoSmithKline |
| 1998 - 1999 | Postdoctoral Researcher, The University of Texas at Austin |
教育
| 2015 | Admitted as a lawyer, England & Wales |
| 2013 | LPC distinction, BPP Law School |
| 2011 | GDL commendation, BPP Law School, London |
| 1997 | PhD in synthetic organic chemistry from Imperial College, London |
| 1994 | BSc Hons Chemistry, Imperial College and Università degli Studi di Firenze, Italy |
Publications
Declaratory Relief in the English Patents Court, Bio-Science Law Review, 2016, p 123-128 |
语言
| English |
最新新闻和观点
专利与创新
点击此处了解更多
Dealing with difficult service in the UPC: The cases of Philips IP Ventures v Belkin and Panasonic v Xiaomi as examples.
2024年1月24日
In-depth analysis
作者
酒店与休闲
点击此处了解更多
Brexit and beyond – Wellcome's recommendations from the Future Partnership Project
2018年3月30日
Briefing
作者 Andrew Payne